Jessica Malaty Rivera is an infectious disease epidemiologist and science communicator. She earned her MS in Emerging Infectious Diseases from the Georgetown School of Medicine and has dedicated the last 15 years of her career to disease surveillance research, public health policy, and vaccine advocacy. Her specialty is in translating complex scientific concepts into impactful, judgment-free, and accessible information for a diverse audience. She is currently the Science Communication Lead for The COVID Tracking Project at The Atlantic, a researcher with the COVID-19 Dispersed Volunteer Research Network, a research affiliate at Boston Children’s Hospital Innovation & Digital Health Accelerator, and an expert contributor for NBC Bay Area and CNN. Jessica was recently named one of the World’s 50 Greatest Leaders by Fortune Magazine for her work on COVID-19 research and data communication. Between her day jobs and being a full-time mother to two little kids, she also dedicates several hours a week to promoting science literacy and debunking misinformation on social media.
Jul 30 2021Blog Post Making Sense of Variants: They All Deserve Attention. A Few Merit Concern. SARS-CoV-2 has already mutated since it was first identified and will continue to do so. Robust global genomic sequencing is the best tool for tracking existing variants and detecting new ones. This information enables public health officials, governments, and communities to take action that can save lives. The more high-quality data that is available, the […] Dr. Rick Bright, Jacqueline Houtman, Jessica Malaty Rivera, Lindsey Shultz, Rebecca Glassman Jul 02 2021Blog Post The U.S. Can Lead the Way in Vaccine Breakthrough Reporting. Will It Squander This Opportunity? Dr. Rick Bright, Jacqueline Houtman, Jessica Malaty Rivera, Lindsey Shultz, Rebecca Glassman